| Name | 4-chloro-5-hydroxy-2-(oxan-2-yl)pyridazin-3-one |
|---|---|
| Synonyms | 3(2H)-Pyridazinone,4-chloro-5-hydroxy-2-(tetrahydro-2H-pyran-2-yl) |
| Molecular Formula | C9H11ClN2O3 |
|---|---|
| Molecular Weight | 230.64800 |
| Exact Mass | 230.04600 |
| PSA | 64.35000 |
| LogP | 1.30140 |
|
~90%
645405-18-1 |
| Literature: NEUROCRINE BIOSCIENCES, INC. Patent: WO2005/103039 A1, 2005 ; Location in patent: Page/Page column 36 ; WO 2005/103039 A1 |
|
~87%
645405-18-1 |
| Literature: Ma, Chen; Cho, Su-Dong; Falck; Shin, Dong-Soo Heterocycles, 2004 , vol. 63, # 1 p. 75 - 85 |
|
~%
645405-18-1 |
| Literature: Dyck, Brian; Markison, Stacy; Zhao, Liren; Tamiya, Junko; Grey, Jonathan; Rowbottom, Martin W.; Zhang, Mingzhu; Vickers, Troy; Sorensen, Katie; Norton, Christi; Wen, Jenny; Heise, Christopher E.; Saunders, John; Conlon, Paul; Madan, Ajay; Schwarz, David; Goodfellow, Val S. Journal of Medicinal Chemistry, 2006 , vol. 49, # 13 p. 3753 - 3756 |